K. Usui, Y. Sasahara, R. Tazawa, K. Hagiwara, S. Tsukada et al., Recurrent pneumonia with mild hypogammaglobulinemia diagnosed as x-linked agammaglobulinemia in adults, Respiratory Research, vol.2, issue.3, pp.188-92, 2001.
DOI : 10.1186/rr56

C. Marguerie, C. Bunn, H. Beynon, R. Bernstein, J. Hughes et al., Polymyositis, Pulmonary Fibrosis and Autoantibodies to Aminoacyl-tRNA Synthetase Enzymes, QJM, vol.77, issue.1, pp.1019-1057, 1990.
DOI : 10.1093/qjmed/77.1.1019

I. Marie, P. Hatron, S. Dominique, C. P. Mouthon, L. Menard et al., Short-Term and Long-Term Outcome of Anti-Jo1-Positive Patients with Anti-Ro52 Antibody, Seminars in Arthritis and Rheumatism, vol.41, issue.6, pp.890-899, 2012.
DOI : 10.1016/j.semarthrit.2011.09.008

C. Wasicek, M. Reichlin, M. Montes, and G. Raghu, Polymyositis and interstitial lung disease in a patient with anti-Jo1 prototype, The American Journal of Medicine, vol.76, issue.3, pp.538-582, 1984.
DOI : 10.1016/0002-9343(84)90677-6

H. Gunawardena, Z. Betteridge, and N. Mchugh, Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression, Rheumatology, vol.48, issue.6, pp.607-619, 2009.
DOI : 10.1093/rheumatology/kep078

B. Hervier and O. Benveniste, [clinical phenotypes and prognosis of antisynthetase syndrome.], Rev Med Interne, 2013.

B. Hervier, H. Devilliers, R. Stanciu, A. Meyer, Y. Uzunhan et al., Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity, Autoimmunity Reviews, vol.12, issue.2, pp.210-217, 2012.
DOI : 10.1016/j.autrev.2012.06.006

S. Levine, N. Raben, D. Xie, F. Askin, R. Tuder et al., Novel conformation of histidyl???transfer RNA synthetase in the lung, Arthritis & Rheumatism, vol.12, issue.8, pp.2729-2768, 2007.
DOI : 10.1002/art.22790

A. Friedman, I. Targoff, and F. Arnett, Interstitial lung disease with autoantibodies againstaminoacyl-tRNA synthetases in the absence of clinically apparent myositis, Seminars in Arthritis and Rheumatism, vol.26, issue.1, pp.459-67, 1996.
DOI : 10.1016/S0049-0172(96)80026-6

B. Hervier, Y. Uzunhan, E. Hachulla, O. Benveniste, H. Nunes et al., Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies, European Respiratory Journal, vol.37, issue.3, pp.714-721, 2011.
DOI : 10.1183/09031936.00104310
URL : https://hal.archives-ouvertes.fr/hal-00873290

E. Katzap, M. Barilla-labarca, and G. Marder, Antisynthetase Syndrome, Current Rheumatology Reports, vol.65, issue.7, pp.175-81, 2011.
DOI : 10.1007/s11926-011-0176-8

W. Felber, The long-term outcome of anti-jo-1-positive inflammatory myopathies, J Neurol, vol.251, pp.859-64, 2004.

A. Labirua and I. Lundberg, Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls, Current Opinion in Rheumatology, vol.22, issue.6, pp.633-641, 2010.
DOI : 10.1097/BOR.0b013e32833f1970

I. Marie, S. Josse, O. Decaux, S. Dominique, E. Diot et al., Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome, Autoimmunity Reviews, vol.11, issue.10, pp.739-784, 2012.
DOI : 10.1016/j.autrev.2012.01.006
URL : https://hal.archives-ouvertes.fr/hal-00872923

L. Goff, B. , C. P. Cantagrel, A. Gayraud, M. Hachulla et al., Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis, Arthritis Care & Research, vol.54, issue.1, pp.108-126, 2009.
DOI : 10.1002/art.24372

A. Labirua-iturburu, A. Selva-o-'callaghan, M. Vincze, K. Danko, J. Vencovsky et al., Anti-PL-7 (Anti-Threonyl-tRNA Synthetase) Antisynthetase Syndrome, Medicine, vol.91, issue.4, pp.206-217, 2012.
DOI : 10.1097/MD.0b013e318260977c
URL : http://doi.org/10.1097/md.0b013e318260977c

I. Marie, S. Josse, P. Hatron, S. Dominique, E. Hachulla et al., Interstitial Lung Disease in Anti-Jo-1 Patients With Antisynthetase Syndrome, Arthritis Care & Research, vol.37, issue.Suppl, pp.800-808, 2013.
DOI : 10.1002/acr.21895

I. Tillie-leblond, M. Wislez, D. Valeyre, B. Crestani, A. Rabbat et al., Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset, Thorax, vol.63, issue.1, pp.53-62, 2008.
DOI : 10.1136/thx.2006.069237

W. Douglas, H. Tazelaar, T. Hartman, R. Hartman, P. Decker et al., Polymyositis???Dermatomyositis-associated Interstitial Lung Disease, American Journal of Respiratory and Critical Care Medicine, vol.164, issue.7, pp.1182-1187, 2001.
DOI : 10.1164/ajrccm.164.7.2103110

T. Fujisawa, T. Suda, Y. Nakamura, N. Enomoto, K. Ide et al., Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis, J Rheumatol, vol.32, pp.58-64, 2005.

V. Foris, G. Kovacs, M. Matucci-cerinic, and H. Olschewski, PL-7 Positive Antisynthetase Syndrome and Pulmonary Hypertension, The Journal of Rheumatology, vol.40, issue.10, pp.1777-1786, 2013.
DOI : 10.3899/jrheum.130403

T. Handa, S. Nagai, D. Kawabata, T. Nagao, M. Takemura et al., Long-term Clinical Course of a Patient with Anti PL-12 Antibody Accompanied by Interstitial Pneumonia and Severe Pulmonary Hypertension, Internal Medicine, vol.44, issue.4, pp.319-344, 2005.
DOI : 10.2169/internalmedicine.44.319

S. Chatterjee and C. Farver, Severe pulmonary hypertension in Anti-Jo-1 syndrome, Arthritis Care & Research, vol.178, issue.3, pp.425-434, 2010.
DOI : 10.1002/acr.20109

I. Targoff and F. Arnett, Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase), The American Journal of Medicine, vol.88, issue.3, pp.241-51, 1990.
DOI : 10.1016/0002-9343(90)90149-8

B. Hervier, A. Meyer, C. Dieval, Y. Uzunhan, H. Devilliers et al., Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival, European Respiratory Journal, vol.42, issue.5, pp.1271-82, 2013.
DOI : 10.1183/09031936.00156312

S. Chow, V. Chandran, R. Fazelzad, and S. Johnson, Prognostic factors for survival in systemic lupus erythematosus associated pulmonary hypertension, Lupus, vol.31, issue.4, pp.353-64, 2012.
DOI : 10.1161/01.CIR.80.5.1198

T. Pan, J. Thumboo, and M. Boey, Primary and secondary pulmonary hypertension in systemic lupus erythematosus, Lupus, vol.9, pp.338-380, 2000.

R. Condliffe, D. Kiely, A. Peacock, P. Corris, J. Gibbs et al., Connective Tissue Disease???associated Pulmonary Arterial Hypertension in the Modern Treatment Era, American Journal of Respiratory and Critical Care Medicine, vol.179, issue.2, pp.151-158, 2009.
DOI : 10.1164/rccm.200806-953OC

E. Hachulla, V. Gressin, L. Guillevin, P. Carpentier, E. Diot et al., Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study, Arthritis & Rheumatism, vol.351, issue.12, pp.3792-800, 2005.
DOI : 10.1002/art.21433

N. Galie, M. Hoeper, M. Humbert, A. Torbicki, J. Vachiery et al., Guidelines for the diagnosis and treatment of pulmonary hypertension, Revista Portuguesa de Cardiologia (English Edition), vol.31, issue.1, pp.1219-63, 2009.
DOI : 10.1016/j.repce.2011.10.006

A. Teixeira, P. Cherin, A. Demoule, M. Levy-soussan, C. Straus et al., Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies, Neuromuscular Disorders, vol.15, issue.1, pp.32-41, 2005.
DOI : 10.1016/j.nmd.2004.09.006

D. Botelho, A. Perez, T. Pouwels, S. Wallaert, B. Hachulla et al., Myopathie des muscles inspiratoires au cours du syndrome des antisynth??tases, La Revue de M??decine Interne, vol.29, issue.4, pp.325-332, 2008.
DOI : 10.1016/j.revmed.2007.09.032

D. Gourcerol, C. Bergoin, L. Thirard, I. Court-fortune, R. Neviere et al., Int??r??t de l?????preuve fonctionnelle d???exercice au cours des myopathies inflammatoires avec atteinte pulmonaire, Revue des Maladies Respiratoires, vol.25, issue.1, pp.13-21, 2008.
DOI : 10.1016/S0761-8425(08)70461-3

E. Ihle, Clinical and serological aspects of patients with anti-jo-1 antibodies--an evolving spectrum of disease manifestations, Clin Rheumatol, vol.19, pp.371-378, 2000.

O. Meyer, H. Charlanne, C. P. Allanore, Y. Coquerelle, P. Grardel et al., Subluxing arthropathy: an unusual manifestation of the antisynthetase syndrome, Annals of the Rheumatic Diseases, vol.68, issue.1, pp.152-155, 2009.
DOI : 10.1136/ard.2007.078907
URL : https://hal.archives-ouvertes.fr/hal-00375864

C. Park, T. Kim, Y. Cho, I. Kim, H. Lee et al., Development of antisynthetase syndrome in a patient with rheumatoid arthritis, Rheumatology International, vol.19, issue.4, pp.529-561, 2011.
DOI : 10.1007/s00296-009-1222-y

L. Cavagna, C. Fusetti, C. Montecucco, and R. Caporali, Anticyclic Citrullinated Peptide Antibodies as Markers of Erosive Arthritis in Antisynthetase Syndrome, The Journal of Rheumatology, vol.37, issue.9, p.68, 1967.
DOI : 10.3899/jrheum.091402

A. Herrick, The pathogenesis, diagnosis and treatment of Raynaud phenomenon, Nature Reviews Rheumatology, vol.23, issue.8, pp.469-79, 2012.
DOI : 10.1038/nrrheum.2012.96

M. Dugar, S. Cox, V. Limaye, P. Blumbergs, and P. Roberts-thomson, Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies, Internal Medicine Journal, vol.70, issue.9, pp.674-683, 2011.
DOI : 10.1111/j.1445-5994.2010.02164.x

A. Selva-o-'callaghan, V. Fonollosa-pla, E. Trallero-araguas, X. Martinez-gomez, C. Simeon-aznar et al., Nailfold Capillary Microscopy in Adults with Inflammatory Myopathy, Seminars in Arthritis and Rheumatism, vol.39, issue.5, pp.398-404, 2010.
DOI : 10.1016/j.semarthrit.2008.09.003

A. Selva-o-'callaghan, M. Labrador-horrillo, R. Solans-laque, C. Simeon-aznar, X. Martinez-gomez et al., Myositis-specific and myositis-associated antibodies in a series of eighty-eight mediterranean patients with idiopathic inflammatory myopathy, Arthritis & Rheumatism, vol.109, issue.5, pp.791-799, 2006.
DOI : 10.1002/art.22237

C. Yang, C. Sheu, T. Ou, J. Hwang, and M. Huang, Combined lung fibrosis and ???mechanic???s hand': A clinical diagnostic clue to amyopathic antisynthetase syndrome, Respirology, vol.28, issue.4, pp.611-615, 2008.
DOI : 10.1007/s10067-005-0111-3

C. Bachmeyer, I. Tillie-leblond, A. Lacert, J. Cadranel, and S. Aractingi, 'Mechanic's hands': a misleading cutaneous sign of the antisynthetase syndrome, British Journal of Dermatology, vol.30, issue.1, pp.192-196, 2007.
DOI : 10.1111/j.1468-3083.2004.00868.x

V. Cottin, B. Crestani, D. Valeyre, B. Wallaert, J. Cadranel et al., Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique. ??labor??es par le centre national de r??f??rence et les centres de comp??tence pour les maladies pulmonaires rares sous l?????gide de la Soci??t?? de pneumologie de langue fran??aise, Revue des Maladies Respiratoires, vol.30, issue.10, pp.879-902, 2013.
DOI : 10.1016/j.rmr.2013.09.007
URL : https://hal.archives-ouvertes.fr/hal-01117879

M. Durey, M. Alyanakian, P. Chretien, S. Chollet-martin, L. Musset et al., Clinical significance of anti-ro52 (trim21) antibodies non-associated with anti-ssa 60kda antibodies: Results of a multicentric study, Autoimmun Rev, vol.10, pp.509-522, 2011.

I. Marie, Morbidity and Mortality in Adult Polymyositis and Dermatomyositis, Current Rheumatology Reports, vol.15, issue.3, pp.275-85, 2012.
DOI : 10.1007/s11926-012-0249-3

F. Ingegnoli, C. Lubatti, A. Ingegnoli, P. Boracchi, S. Zeni et al., Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: A single centre study and review of the literature, Autoimmunity Reviews, vol.11, issue.5, pp.335-375, 2012.
DOI : 10.1016/j.autrev.2011.09.007

E. Choy and D. Isenberg, Treatment of dermatomyositis and polymyositis, Rheumatology, vol.41, issue.1, pp.7-13, 2002.
DOI : 10.1093/rheumatology/41.1.7

K. Briot and C. Roux, Ost??oporose cortico-induite, La Revue de M??decine Interne, vol.34, issue.5, pp.315-338, 2013.
DOI : 10.1016/j.revmed.2012.11.005

M. Kalluri, S. Sahn, C. Oddis, S. Gharib, L. Christopher-stine et al., Clinical Profile of Anti-PL-12 Autoantibody, Chest, vol.135, issue.6, pp.1550-1556, 2009.
DOI : 10.1378/chest.08-2233

L. Cavagna, R. Caporali, L. Abdi-ali, R. Dore, F. Meloni et al., Cyclosporine in Anti-Jo1-positive Patients with Corticosteroid-refractory Interstitial Lung Disease, The Journal of Rheumatology, vol.40, issue.4, pp.484-92, 2013.
DOI : 10.3899/jrheum.121026

R. Aggarwal and C. Oddis, Therapeutic advances in myositis, Current Opinion in Rheumatology, vol.24, issue.6, pp.635-676, 2012.
DOI : 10.1097/BOR.0b013e328358ac72

Y. Yamasaki, H. Yamada, M. Yamasaki, M. Ohkubo, K. Azuma et al., Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis, Rheumatology, vol.46, issue.1, pp.124-154, 2007.
DOI : 10.1093/rheumatology/kel112

M. Wilkes, S. Sereika, N. Fertig, M. Lucas, and C. Oddis, Treatment of antisynthetase-associated interstitial lung disease with tacrolimus, Arthritis & Rheumatism, vol.6, issue.8, pp.2439-2485, 2005.
DOI : 10.1002/art.21240

B. Hervier, A. Masseau, J. Mussini, M. Audrain, and M. Hamidou, Long-term efficacy of mycophenolate mofetil in a case of refractory antisynthetase syndrome, Joint Bone Spine, vol.76, issue.5, pp.575-581, 2009.
DOI : 10.1016/j.jbspin.2009.02.004

A. Labirua-iturburu, A. Selva-o-'callaghan, X. Martinez-gomez, E. Trallero-araguas, M. Labrador-horrillo et al., Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease, Clin Exp Rheumatol, vol.31, pp.436-445, 2013.

A. Schnabel, M. Reuter, J. Biederer, C. Richter, and W. Gross, Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment, Seminars in Arthritis and Rheumatism, vol.32, issue.5, pp.273-84, 2003.
DOI : 10.1053/sarh.2002.50012

I. Marie, P. Hatron, C. P. Hachulla, E. Diot, E. Vittecoq et al., Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome, Arthritis Research & Therapy, vol.15, issue.5, p.149, 2013.
DOI : 10.1111/j.1365-2133.2009.09484.x
URL : https://hal.archives-ouvertes.fr/inserm-00903872

D. Bozkirli, I. Kozanoglu, E. Bozkirli, and E. Yucel, Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis, Journal of Clinical Apheresis, vol.25, issue.6, pp.422-427, 2013.
DOI : 10.1002/jca.21285

P. Cherin, S. Pelletier, A. Teixeira, P. Laforet, T. Genereau et al., Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: An open study with thirty-five adult patients, Arthritis & Rheumatism, vol.24, issue.2, pp.467-74, 2002.
DOI : 10.1002/art.10053

M. Sem, O. Molberg, M. Lund, and J. Gran, Rituximab treatment of the anti-synthetase syndrome--a retrospective case series, Rheumatology, vol.48, issue.8, pp.968-71, 2009.
DOI : 10.1093/rheumatology/kep157

I. Marie, S. Dominique, A. Janvresse, H. Levesque, and J. Menard, Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome, Respiratory Medicine, vol.106, issue.4, pp.581-588, 2012.
DOI : 10.1016/j.rmed.2012.01.001

F. Frikha, A. Rigolet, A. Behin, B. Fautrel, S. Herson et al., Efficacy of rituximab in refractory and relapsing myositis with anti-JO1 antibodies: a report of two cases, Rheumatology, vol.48, issue.9, pp.1166-1174, 2009.
DOI : 10.1093/rheumatology/kep147

M. Dastmalchi, C. Grundtman, H. Alexanderson, C. Mavragani, H. Einarsdottir et al., A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies, Annals of the Rheumatic Diseases, vol.67, issue.12, pp.1670-1677, 2008.
DOI : 10.1136/ard.2007.077974